Neuro- and Biofeedback in Nonsuicidal Self-injury
Examining the Effects of Real-time fMRI Neurofeedback and Biofeedback in Adolescents With Nonsuicidal Self-injury
1 other identifier
interventional
60
1 country
1
Brief Summary
Nonsuicidal self-injury (NSSI) is defined as the direct, deliberate destruction of one's own body tissue without suicidal intent, typically including behaviors such as cutting, burning, or hitting oneself. The risk of engaging in NSSI is particularly high during adolescence. NSSI is associated with impairments in emotion regulation and NSSI behavior serves as an attempt to regulate emotion. We propose to examine whether training adolescents with NSSI to self-regulate using emotion regulation skills to down-regulate hemodynamic activity of the salience network, involved in emotional processing. Moreover, we propose to examine whether limbic-prefrontal cortex connectivity can be increased following neurofeedback, thereby helping adolescents find an optimal way to emotionally regulate with the help of neurofeedback, instead of engaging in NSSI to regulate emotions. We also aim to examine effects of real-time biofeedback by investigating if adolescents can regulate their psychophysiological activity during emotional reactivity with biofeedback. Sixty participants with NSSI will be recruited and offered either real-time functional magnetic resonance imaging (rt-fMRI-NF) (n = 30) or real-time biofeedback (n = 30) training. Participants each each condition will then be randomized to either an active or a control condition (n = 15/group). Participants will take part in three runs of feedback training. Changes in emotional reactivity as measured with facial electromyography (EMG) before and after feedback training will be the proximal outcome measure together with changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. Proximal outcome measures for the biofeedback will include psychophysiological measures of emotional reactivity (facialEMG). More distal outcome measures for both neuro- and biofeedback will be measures of NSSI: frequency, methods and severity as well as self-report measures of difficulties with regulating emotions, emotional reactivity and psychiatric symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2021
CompletedFirst Submitted
Initial submission to the registry
January 31, 2022
CompletedFirst Posted
Study publicly available on registry
December 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedAugust 29, 2023
August 1, 2023
2.2 years
January 31, 2022
August 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Emotional reactivity
Changes of emotional reactivity is measured with facial electromyography (facialEMG). High zygomatic and corrugator response indicate higher emotional reactivity.
Change from baseline up to 5 weeks
Hemodynamic activity
Changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. The aim is to down-regulate the hemodynamic activity in the salience network.
Change from baseline at up to 4 weeks
Psychophysiological response
Changes of psychophysiological response during the real-time biofeedback training. The aim is to decrease the emotional reactivity and psychophysiological response.
Change from baseline at up to 4 weeks
Secondary Outcomes (7)
Nonsuicidal self-injury
Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up
Difficulties with emotion regulation
Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up
Emotional reactivity
Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up
Emotional awareness
Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up
Psychiatric symptoms
Change from baseline at up to 5 weeks, and at additional 6 weeks and 3 month follow-up
- +2 more secondary outcomes
Study Arms (2)
real-time functional magnetic resonance imaging neurofeedback and real-time biofeedback
EXPERIMENTALThree sessions of real-time functional magnetic resonance imaging neurofeedback (rt-fMRI-NF) or real-time biofeedback training where participants will receive direct visual feedback from the blood oxygenation level dependent (BOLD) imaging signaling from the salience network in rt-fMRI-NF or visual feeback from a physiological signal in the real-time biofeedback (active condition)
Sham feedback
SHAM COMPARATORThree session where participants will be given a yoked sham feedback as control condition.
Interventions
Participants will take part in three runs of real-time functional magnetic resonance imaging feedback (rt-fMRI-NF) training with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive biofeedback will take part in three runs of biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).
Participants will take part in three runs of sham neurofeedback with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive sham biofeedback will take part in three runs of sham biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).
Eligibility Criteria
You may qualify if:
- ongoing contact at the child- and adolescent psychiatric clinics in both Linköping and Norrköping, Sweden
- ongoing contact at the primary care facilities in Linköping and Norrköping (Ungdomshälsan, Råd, Stöd \& Hälsa)
- NSSI, independent of psychiatric diagnosis
- between 15 and 19 years of age
- having engaged in five or more instances of NSSI during the last six months
- the patient is cognitively capable to decide for him- or herself
You may not qualify if:
- anorexia in starvation with BMI 16 or under
- substance abuse disorder
- psychosis
- needing interpreter
- intellectual disability
- and for those who do the neurofeedback, severe claustrophobia, pregnancy and braces
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Region Östergötland
Linköping, 581 85, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Zetterqvist, PhD
Region Östergötland and Linköping university
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The participants and the outcomes assessor will not know if the participants receive actual or sham feedback.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 31, 2022
First Posted
December 19, 2022
Study Start
September 10, 2021
Primary Completion
December 1, 2023
Study Completion
March 1, 2024
Last Updated
August 29, 2023
Record last verified: 2023-08